The effects of macronutrients on blood pressure and lipids: An overview of the DASH and omniheart trials
- 346 Downloads
Macronutrients are those nutrients (protein, fat, and carbohydrate) that provide energy. The purpose of this review is to highlight findings of three large-scale, isocaloric feeding studies: the Dietary Approaches to Stop Hypertension (DASH) trial, the DASH-Sodium trial, and the Optimal Macro-Nutrient Intake to Prevent Heart Disease (OmniHeart) trial. Each of these trials tested the effects of diets with different macronturient profiles on traditional cardiovascular disease (CVD) risk factors (ie, blood pressure and blood lipids) in the setting of stable weight. The DASH and DASH-sodium trials demonstrated that a carbohydrate-rich diet that emphasizes fruits, vegetables, and low-fat dairy products and that is reduced in saturated fat, total fat, and cholesterol substantially lowered blood pressure and low-density lipoprotein cholesterol. OmniHeart demonstrated that partial replacement of carbohydrate with either protein (about half from plant sources) or with unsaturated fat (mostly monounsaturated fat) can further reduce blood pressure, low-density lipoprotein cholesterol, and coronary heart disease risk. Results from these trials highlight the importance of macronutrients as a determinant of CVD risk. Furthermore, these results also document substantial flexibility that should enhance the ability of individuals to consume a heart-healthy diet.
KeywordsDietary Pattern Control Feeding Study UNSAT Diet Carb Diet
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Keys A: Coronary Heart Disease in Seven Countries. New York: American Heart Association Monograph; 1970, Number 29.Google Scholar
- 10.Yokoyama M: JELIS-Japan Eicosapentaenoic acid (EPA) Lipid Intervention Study. Presented at the American Heart Association 2005 Scientific Sessions. November 13–16, 2005, Dallas, TX.Google Scholar
- 11.GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico): Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354:447–455.CrossRefGoogle Scholar
- 12.Balk E, Chung M, Lichtenstein A, et al.: Effects of Omega-3 Fatty Acids on Cardiovascular Disease Risk Factors and Intermediate Markers of Cardiovascular Disease. EPC report No.93, AHRQ report no 04-E010-2. Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar